What We Do
We develop novel therapeutics to dramatically improve outcomes for cancer patients, using world-leading innovation in p27 biology
Featured In
01
Many startups are built off research, so why don’t more scientists become founders?
02
CDK Inhibitors: Why Women – and Men – Should Know About
This ‘New Era’ Of Cancer Treatment
03
The academic to founder pipeline with Dr. Stacy Blain from
Concarlo Therapeutics
04
FORCE Family: Opportunity to Join the Fight Against Metastatic Breast Cancer
05
FORCE Family:
Cancer Moonshoot Webinar
06
Drug Discovery World: US Biotech Start-up Set to Have Huge Impact on Breast Cancer Treatment Landscape
07
BioCentury: Concarlo: Targeting proliferation
and resistance in one go
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
RESI’s Innovator’s Pitch Challenge Winner
Princeton University Women’s Showcase
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
